MET and hepatocellular carcinoma: At the end of the experiment, it was satisfactory to observe that HCC in one (still with HA-AKT and V5-c-Met overexpression, data not shown) 2 mg celastrol-administered AKT/c-Met mouse became invisible and the mouse instead appeared healthy with a normal liver size.